F Eun-Hyung Lee Selected Research

F Eun-Hyung Lee Research Topics

Disease

15	Infections 01/2023 - 02/2003
12	COVID-19 06/2023 - 05/2020
9	Human Influenza (Influenza) 03/2024 - 11/2005
8	Asthma (Bronchial Asthma) 02/2024 - 12/2004
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2024 - 06/2010
4	Autoimmune Diseases (Autoimmune Disease) 03/2024 - 02/2008
4	Respiratory Syncytial Virus Infections 11/2011 - 09/2004
3	Virus Diseases (Viral Diseases) 11/2011 - 06/2007
2	Allergic Bronchopulmonary Aspergillosis 01/2023 - 02/2020
2	Nasal Polyps (Nasal Polyp) 01/2023 - 01/2021
2	Hepatitis B 08/2013 - 05/2011
1	Tetanus 03/2024
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2024
1	Fatigue 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Lyme Disease (Disease, Lyme) 01/2023
1	Allergic Fungal Sinusitis 01/2023
1	Cognitive Dysfunction 01/2023
1	Clostridium Infections 01/2022
1	Allergic Rhinitis 01/2021
1	Hypoxia (Hypoxemia) 12/2018
1	Nephritis 10/2018
1	Inflammation (Inflammations) 10/2018
1	Neoplasms (Cancer) 01/2018
1	Multiple Myeloma 01/2016
1	Mumps 07/2015
1	Measles 07/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2011
1	Rheumatoid Arthritis 01/2011
1	Malaria 03/2009
1	Acute-Phase Reaction 12/2004
1	Pneumonia (Pneumonitis) 12/2004

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 03/2022 - 09/2004
8	AntibodiesIBA 11/2022 - 01/2011
7	CytokinesIBA 03/2024 - 02/2003
7	Proteins (Proteins, Gene)FDA Link 07/2021 - 02/2006
5	Immunoglobulin G (IgG)IBA 03/2024 - 01/2009
5	AutoantibodiesIBA 03/2024 - 07/2015
5	AntigensIBA 01/2013 - 01/2009
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2021
4	Neutralizing AntibodiesIBA 12/2020 - 09/2004
4	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2017 - 01/2009
3	mRNA VaccinesIBA 03/2024 - 01/2022
3	COVID-19 VaccinesIBA 02/2024 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 12/2021
2	dupilumabIBA 01/2023 - 02/2020
2	Antiviral Agents (Antivirals)IBA 01/2023 - 09/2004
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 12/2004
2	Respiratory Syncytial Virus VaccinesIBA 04/2016 - 09/2004
2	Peptides (Polypeptides)IBA 01/2013 - 02/2006
1	Complement System Proteins (Complement)IBA 01/2023
1	remdesivirIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	mepolizumabIBA 10/2022
1	Immunoglobulin A (IgA)IBA 12/2021
1	Bispecific AntibodiesIBA 04/2021
1	Monoclonal AntibodiesIBA 04/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 05/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2018
1	Immunoglobulin D (IgD)IBA 10/2018
1	Toll-Like Receptor 7IBA 10/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2018
1	EicosanoidsIBA 10/2018
1	Arachidonic Acid (Vitamin F)IBA 10/2018
1	EndocannabinoidsIBA 10/2018
1	Broadly Neutralizing AntibodiesIBA 01/2018
1	Inactivated VaccinesIBA 04/2016
1	Formaldehyde (Formol)FDA Link 04/2016
1	EpitopesIBA 01/2016
1	ChemokinesIBA 01/2014
1	ProteomeIBA 01/2013
1	flopropioneIBA 01/2013
1	SteroidsIBA 11/2011
1	Glycoproteins (Glycoprotein)IBA 05/2011
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 05/2011
1	NucleoproteinsIBA 05/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011
1	LigandsIBA 03/2009
1	Malaria VaccinesIBA 03/2009
1	Hemagglutinins (Hemagglutinin)IBA 01/2009
1	Interleukin-5 (Interleukin 5)IBA 06/2007
1	InterleukinsIBA 06/2007
1	Interleukin-2 (IL2)IBA 02/2006
1	Protein Subunit VaccinesIBA 02/2006
1	aluminum sulfate (alum)IBA 02/2006
1	Interleukin-10 (Interleukin 10)IBA 11/2005
1	CarbonIBA 12/2004
1	Oxidants (Oxidizing Agents)IBA 12/2004

Therapy/Procedure

5	Therapeutics 02/2024 - 06/2010
3	Biological Therapy 01/2022 - 01/2022
1	Immunotherapy 02/2024
1	Intramuscular Injections 12/2010